English Other languages Società

Comirnaty and Spikevax: EMA recommendations on extra doses and boosters

4 Ottobre 2021 by

… Although there is no direct evidence

… protected against COVID-19

… it is expected

… would increase protection at least in some patients

… will continue monitoring any data that emerges on its effectiveness

… taking into account emerging effectiveness data and the limited safety data

… risk of inflammatory heart conditions or other very rare side effects after a booster is not known

 

Share: